Vivo Capital, LLC Uni Qure N.V. Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $1.03 Million - $1.55 Million	-22,932 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $917,509 - $1.7 Million	22,932 New	22,932 $1.09 Million
Q2 2019 Aug 13, 2019	SELL	$52.76 - $82.19 $9.51 Million - $14.8 Million	-180,336 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$27.39 - $68.41 $4.94 Million - $12.3 Million	180,336 New	180,336 $10.8 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.